Presentation of Nancy Thornberry – University of Copenhagen

Forward this page to a friend Resize Print Bookmark and Share

Novo Nordisk Foundation Center for Basic Metabolic Research > About the Center > Scientific Advisory Board > Presentation of Nancy ...

Presentation of Nancy Thornberry

Nancy Thornberry, PhD, CEO of Kallyope, New York, USA, and Director at Intarcia Therapeutics and Abide Therapeutics, Boston. She was formerly Senior Vice President and Franchise Head for Diabetes and Endocrinology at Merck & Co. Inc. Prior to her role as Franchise Head, Nancy Thornberry initiated and was a leader of Merck’s dipeptidyl peptidase 4 (DPP-4) project, which resulted in the discovery of JANUVIA® for the treatment of Type 2 diabetes.

She has received numerous awards, including the Merck Presidential Fellowship, Merck Directors Award, Heroes of Chemistry Award by the American Chemical Society, and the PhRMA Award. Her current research focus is integrating sequencing, bioinformatics, neural imaging, cellular and molecular biology, and human genetics to provide an understanding of gut-brain biology in order to improve human health and nutrition.

Dr. Nancy Thornberry has been member of the SAB since 2016.